Who Owns ALGS?

Aligos Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$6.31

-0.12 (-1.87%)

Market Cap

$43.2M

Shares Outstanding

6,187,806

Institutional Holders

35

Total Inst. Value

$25.2M

% of Float Held

QoQ Holder Change

-6

Institutional data as of Q1 2025

New Positions

12

Closed Positions

9

Increased

10

Decreased

8

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ADAGE CAPITAL PARTNERS GP, L.L.C.$3.8M465,000
2Deep Track Capital, LP$3.7M444,110
3Alyeska Investment Group, L.P.New$3.4M412,000
4Woodline Partners LPNew$2.6M315,383
5HEIGHTS CAPITAL MANAGEMENT, INCNew$2.0M241,500
6Sio Capital Management, LLCNew$1.5M180,720
7BANK OF AMERICA CORP /DE/$1.3M154,503
8TANG CAPITAL MANAGEMENT LLCNew$1.2M141,131
9VANGUARD GROUP INC$1.2M140,749
10EcoR1 Capital, LLC$731K88,569

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
EcoR1 Capital, LLC-167K$731K
Vivo Capital, LLC-132K$84K
Trexquant Investment LP-31K$316K
ROYAL BANK OF CANADA-21K$18K
UBS Group AG-7K$70K

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold ALGS?

As of Q1 2025, 35 institutional investors report holding ALGS (Aligos Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most ALGS?

The largest institutional holder of ALGS is ADAGE CAPITAL PARTNERS GP, L.L.C. with $3.8M in shares.

Are institutions buying or selling ALGS?

This quarter, 12 institutions opened new positions in ALGS and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.